Welcome to our dedicated page for Cooper SEC filings (Ticker: COO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cooper Companies, Inc. filings document a Nasdaq-listed medical device company with common stock trading under the symbol COO. Its regulatory disclosures include Form 8-K reports on quarterly results, board and officer changes, annual meeting voting results, and material definitive agreements, including amendments to term loan arrangements.
Proxy materials describe director elections, board committee matters, executive compensation, shareholder proposals, and governance practices. Together, the filings record operating and financial disclosures for CooperVision and CooperSurgical, capital structure information, debt arrangements, stockholder voting mechanics, and risk and governance topics relevant to the company’s contact lens, fertility, and women’s healthcare businesses.
Cooper Companies reported that officer Holly R Sheffield, President, CSI, acquired 1,230 shares of its common stock on 12/16/2025 at $80.75 per share.
Following this purchase, she beneficially owned 39,052 shares, held directly. The filing shows no derivative securities transactions related to this trade.
Cooper Companies' President, CEO and director Albert G. White III reported buying 10,000 shares of Cooper Companies, Inc. common stock on 12/16/2025 at a price of $80.8 per share. After this reported open-market purchase, he directly beneficially owns 236,151 shares of the company’s common stock. This filing reflects an increase in the personal equity stake of a key executive and board member in Cooper Companies.
Cooper Companies director Robert S. Weiss reported a charitable gift of company stock. On 12/12/2025, he disposed of 7,500 shares of Cooper Companies common stock in a transaction coded "G," which the footnotes describe as a gift to a charitable donor-advised fund.
After this transaction, Weiss beneficially owns 257,860 shares indirectly through the Robert and Marilyn Weiss Trust dated 5/17/06, where he and his spouse serve as co-trustees, and 288,945 shares directly. The filing reflects an insider’s charitable transfer rather than an open-market sale.
On December 9, 2025, The Cooper Companies, Inc. assigned its Executive Vice President, Chief Financial Officer and Treasurer, Brian G. Andrews, the additional role of principal accounting officer, taking over that responsibility from Agostino Ricupati.
Mr. Ricupati will continue serving as the company’s Senior Vice President, Tax. The company states there are no special arrangements, family relationships, related-party transactions or compensation changes associated with Mr. Andrews’ assumption of the principal accounting officer role.
Cooper Companies reported an insider equity award for its President & CEO, who is also a director. On December 9, 2025, the executive received 42,306 performance stock units (PSUs) and 84,613 restricted stock units (RSUs), each tied to shares of common stock and reported as directly owned derivative securities at an exercise price of $0.00.
The PSUs will vest based on total shareholder return performance relative to an index over a three-year period ending October 31, 2028, with between 0% and 200% of the target PSUs eligible to vest; none vest if minimum performance is not met. The RSUs vest 25% per year over four years, with a January 8 vesting date beginning on January 8, 2026, and will either vest or be forfeited.
Cooper Companies reported that officer Holly R. Sheffield, President of CSI, received new equity awards on 12/09/2025. The grants consist of 7,960 Performance Stock Units and 15,921 Restricted Stock Units, each with an exercise price of $0.00 and each linked to an equivalent number of shares of common stock. Following these grants, 7,960 PSUs and 15,921 RSUs are beneficially owned directly.
The PSUs will vest based on The Cooper Companies, Inc. total shareholder return performance relative to an index over a three-year performance period ending October 31, 2028, with between 0% and 200% of the target number eligible to vest and no shares vesting if minimum performance is not achieved. The RSUs vest 25% per year over four years on January 8 of each year beginning on January 8, 2026, and any units that do not vest will be forfeited.
The Cooper Companies reported new equity awards to its EVP & Chief Operating Officer dated 12/09/2025.
The filing shows a grant of 10,508 Performance Stock Units that will vest based on total shareholder return performance relative to an index over a three-year period ending October 31, 2028. Between 0% and 200% of the target PSUs may vest depending on performance, and no shares will vest if minimum TSR performance is not achieved. These PSUs have no expiration date and settle after performance results are certified.
The officer also received 21,016 Restricted Stock Units that vest 25% per year over four years, with a January 8 vesting date beginning on January 8, 2026. This award has no expiration date; the RSUs will either vest or be forfeited. Both awards relate to shares of the company’s common stock and are held directly.
Lawrence E. Kurzius, a director of Cooper Companies, Inc. (COO), reported a purchase of 2,000 shares of the company's common stock on 09/29/2025 at a price of $68.39 per share. After the transaction, he beneficially owned 5,777 shares, held directly. The Form 4 was signed on 09/29/2025 by Kurzius via attorney-in-fact Nicholas Khadder. The filing uses transaction code P indicating a purchase and lists Kurziuss business address in San Ramon, CA.
Albert G. White III, President & CEO and Director of Cooper Companies (COO), reported an insider purchase of 10,000 shares at $68.39 on 09/05/2025, increasing his beneficial ownership to 226,151 shares. The Form 4 was filed individually and signed by an attorney-in-fact on behalf of Mr. White.
Gerard H. Warner III, President of CooperVision and an officer of Cooper Companies (COO), acquired 1,450 shares of Company common stock on 09/05/2025 at $69.23 per share. After the purchase he beneficially owned 18,319 shares. The Form 4 was submitted by a single reporting person and signed by an attorney-in-fact on behalf of Mr. Warner.